Highlights Suven Pharmaceuticals Limited Bombay S.E.

Equities

SUVENPHAR

INE03QK01018

Delayed Bombay S.E. Other stock markets 02:55:53 2024-05-21 EDT			5-day change	1st Jan Change
634.3 ^INR	-1.77%		-2.39%	-12.65%

03-27	Suven Pharmaceuticals Limited Announces Shifting of Registered Office	CI
03-05	Transcript : Cohance Lifesciences Limited, Suven Pharmaceuticals Limited - M&A Call

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Indian shares set to rise on strong domestic growth, in-line US inflation data	02-29	RE
Suven Pharmaceuticals Limited agreed to acquire Cohance Lifesciences Limited for INR 81,340.421103 million	02-28	CI
US FDA Clears Suven Pharmaceuticals' API and Formulations Plants in Hyderabad, India	02-23	MT
Suven Pharmaceuticals' Consolidated Net Profit Declines in Fiscal Q3	02-06	MT
Suven Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-05	CI
Suven Pharmaceuticals Limited Approves Interim Dividend for the Financial Year 2023-24	12-15	CI
Suven Pharmaceuticals Limited Proposes Interim Dividend for the Financial Year 2022-23	11-22	CI
Suven Pharmaceuticals Posts Gains in Fiscal Q2 Consolidated Profit	11-14	MT
Suven Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-09	CI
Berhyanda Limited completed the acquisition of 0.001% stake in Suven Pharmaceuticals Limited for INR 1.3 million.	11-02	CI
Advent International Corporation completed the acquisition of 50.1% stake in Suven Pharmaceuticals Limited from Jasti Family.	23-09-28	CI
Suven Pharmaceuticals Clocks Gains in Fiscal Q1 Consolidated Net Profit	23-08-09	MT
Suven Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-08	CI
Suven Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-25	CI
Indian shares set for muted open on risk aversion amid Q4 earnings	23-04-20	RE
Suven Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-06	CI
Li & Fung considers options for $500 mln Asia healthcare arm, including a sale - sources	23-01-16	RE
Advent to Acquire Majority Stake in Suven Pharmaceuticals	22-12-27	MT
Advent to buy 'significant' stake in India's Suven Pharma, explore merger	22-12-25	RE
Berhyanda Limited made an offer to acquire 26% stake in Suven Pharmaceuticals Limited for INR 32.8 billion.	22-12-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Suven Pharmaceuticals Limited Bombay S.E.

Equities

SUVENPHAR

INE03QK01018

Highlights

Filters